Outcomes Of Laparoscopic Sleeve Gastrectomy In Patients With Hypothyroidism And Depression
Condition(s) studied
Investigational drug(s) / intervention(s)
laparoscopic sleeve gastrectomy: laparoscopic sleeve gastrectomy is one of the popular bariatric surgeries known for weight reduction
Study summary
Sleeve gastrectomy (SG) continues to be one of the most popular bariatric procedures all over the world. It has been established that obesity is a predisposing factor for several comorbidities, including life-threatening conditions. Many studies have discussed the impact of sleeve gastrectomy on TSH level. But, since most obese patients have some sort of depression, we will try to study the impact of sleeve gastrectomy, depression and hypothyroidism on each other.
Eligibility
Primary outcome measure(s)
- thyroid function tests — from one day to one year after surgery
TSH,T3,T4 are measured pre and post operative - depression — from one day to one year after surgery
depression status is compared pre-operative and post-operative using depression questionnaire (PHQ-9)( patient health questionnaire-9) - weight — from one day to one year after surgery
weight of the patient will be measured in Kg using weight scale - dose of thyroid replacement therapy — monthly from one day to one year post surgery.
the dose of L-thyroxin is monitored in microgrames - gasteric leakage — from one day to 1 week post-surgery
leakage after surgery from staple line measured in ml in the drain - wound infection — from one day to 2 weeks post-surgery
wound infection will be identified by pus in the drain or in the wound
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Faculty of Medicine | Zagazig | Sharqia Province | |
| Zagazig University Hospitals | Zagazig | Egypt |
More Zagazig University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06859320 on ClinicalTrials.gov ↗ ← All trials in Egypt